期刊文献+

CK7、CK20、Villin、CDX-2、MUC-2、PAX8在卵巢原发性黏液性肿瘤和继发性腹膜假黏液瘤中的表达及鉴别诊断意义 被引量:3

Expression of CK7,CK20,Villin,CDX-2,MUC-2 and PAX8 in primary ovarian mucinous neoplasms and secondary pseudomyxoma peritonei and their implications in differential diagnosis
下载PDF
导出
摘要 目的探讨CK7、CK20、Villin、CDX-2、MUC-2、PAX8在卵巢原发性黏液性肿瘤(OPMN)和卵巢继发性腹膜假黏液瘤(OS-PMP)中的表达及鉴别意义。方法收集经组织学和临床资料证实的OPMN 22例,OS-PMP 31例,采用免疫组化EnVision两步法检测CK7、CK20、Villin、CDX-2、MUC-2、PAX8的表达。结果CK7、PAX8在OPMN中的阳性率显著高于OS-PMP(分别为100%vs.9.7%,63.6%vs.0)(P<0.01)。CK20、CDX2、MUC2在OSPMP中的阳性率显著高于OPMN(分别为100%vs.9.1%,100%vs.18.2%,100%vs.9.1%)(P<0.01)。Villin在OS-PMP中的阳性率显著高于OPMN(100%vs.68.2%)(P<0.05)。CK7、CK20、CDX-2、MUC-2在OS-PMP诊断中均具有较高的敏感性(分别为90.3%、100%、100%、100%)及特异性(分别为100%、90.9%、81.8%、90.9%)。而Villin、PAX8敏感度性(100%),但特异性较低(分别为31.8%、54.5%)。结论CK7、CK20、Villin、CDX-2、MUC-2、PAX8推荐用于任何临床或病理特征提示继发性起源的卵巢黏液性肿瘤。CK7、CK20、CDX-2、MUC-2是高度敏感性及特异性的免疫组化鉴别诊断标志物。 Objective To investigate the expression and differential significance of CK7,CK20,Villin,CDX-2,MUC-2 and PAX8 in ovarian primary mucinous neoplasms(OPMN)and ovarian secondary pseudomyxoma peritonei(OS-PMP).Methods A total of 22 OPMN and 31 OS-PMP confirmed by histological and clinical data were collected.The expression of CK7,CK20,Villin,CDX-2,MUC-2 and PAX8 was detected by immunohistochemical EnVision method.Results The expression of CK7 and PAX8 in OPMN was significantly higher than those in OS-PMP(100%vs.9.7%,63.6%vs.0,respectively)(P<0.01).The expression of CK20,CDX2 and MUC2 in OS-PMP was significantly higher than those in OPMN(100%vs.9.1%,100%vs.18.2%,100%vs.9.1%,respectively)(P<0.01).The expression of Villin in OSPMP was significantly higher than that of OPMN(100%vs.68.2%)(P<0.05).CK7,CK20,CDX-2 and MUC-2 showed high sensitivity(90.3%,100%,100%,100%,respectively)and specificity(100%,90.9%,81.8%,90.9%,respectively)in OS-PMP.Villin and PAX8 showed high sensitivity(100%)but low specificity(31.8%and 54.5%,respectively).Conclusion CK7,CK20,Villin,CDX-2,MUC-2 and PAX8 are recommended in the work-up of ovarian mucinous tumors with any clinical or pathological features suggestive of secondary origin.CK7,CK20,CDX-2 and MUC-2 are highly sensitive and specific immunohistochemical markers for the differential diagnosis.
作者 李方 刘赛娜 齐长海 柏明见 侯芳 卢一艳 郝志红 李珂敏 马瑞卿 LI Fang;LIU Sai-na;QI Chang-hai;BAI Ming-jian;HOU Fang;LU Yi-yan;HAO Zhi-hong;LI Ke-min;MA Rui-qing(Department of Pathology,Aerospace Center Hospital,Beijing100049,China;Department of Clinical Laboratory,Aerospace Center Hospital,Beijing100049,China;Department of Myxoma,Aerospace Center Hospital,Beijing100049,China)
出处 《诊断病理学杂志》 2023年第7期643-647,共5页 Chinese Journal of Diagnostic Pathology
基金 航天中心医院院级课题(YN201915)。
关键词 腹膜假黏液瘤 卵巢黏液性肿瘤 阑尾肿瘤 免疫组化 Pseudomyxoma peritonei Ovarian mucinous neoplasm Appendiceal neoplasm Immunohistochemistry
  • 相关文献

参考文献1

二级参考文献24

  • 1崔书中,巴明臣,唐鸿生.腹腔热灌注化疗技术方法变迁及展望[J].中华临床医师杂志(电子版),2011,5(7):2039-2042. 被引量:36
  • 2郭爱桃,宋欣,韦立新.女性腹膜假黏液瘤的组织学起源分析[J].临床与实验病理学杂志,2007,23(1):62-66. 被引量:17
  • 3Ronnett BM, Zahn CM, Kurman peritoneal adenomucinosis and R J, et al. Disseminated peritoneal mucinous carcinomatosis. A clinicopathologie analysis of 109 cases with emphasis on distinguishing pathologic features, site of origin, prognosis, and relationship to "pseudomyxoma peritonei". Am J Surg Pathol, 1995,19 : 1390-1408.
  • 4Bradley RF, Stewart JH 4th, Russell GB, et al. Pseudomyxoma peritonei of appendiceal origin: a clinicopathologic analysis of 101 patients uniformly treated at a single institution, with literature review. Am J Surg Pathol,2006 ,30 :551-559.
  • 5Jacquet P, Sugarbaker PH. Clinical research methodologies in diagnosis and staging of patients with peritoneal carcinomatosis. Cancer Treat Res, 1996,82 : 359-374.
  • 6Pai RK, Beck AH, Norton JA, et al. Appendicea! mucinous neoplasms: clinicopathologic study of 116 cases with analysis of factors predicting recurrence. Am J Surg Pathol,2009,33:1425- 1439.
  • 7van Ruth S, Acherman YI, van de Vijver MJ, et al. Pseudomyxoma peritonei : a review of 62 cases. Eur J Surg Oncol, 2003,29:682-688.
  • 8Szych C, Staebler A, Connolly DC, et al. Molecular genetic evidence supporting the clonality and appendiceal origin of Pseudomyxoma peritonei in women. Am J Pathol, 1999, 154: 1849 -1855.
  • 9Ronnett BM, Yan H, Kurman R3, ct al. Patients with pseudomyxoma peritonei associated with disseminated peritoneal adenomucinosis have a significantly more favorable prognosis than patients with peritoneal mucinous carcinomatosis. Cancer, 2001, 92:85-91.
  • 10Bosman FT, Carneiro F, Hmban RH, et al. World Health Organization classification of tumors of the digestive system. Lyon : IARC Press ,2010:316-317.

共引文献1

同被引文献24

引证文献3

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部